Work

Interferon‐γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti–tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis

Year: 2012

Type: article

Source: Arthritis & Rheumatism

DOI: 10.1002/art.34382

Authors: Elizabeth C. Hsia, Neil Schluger, John J. Cush, Richard E. Chaisson, Eric L. Matteson, Stephen Xu, Anna Beutler, Mittie K. Doyle, Benjamin Hsu, Mahboob U. Rahman

Institutions: Johnson & Johnson (United States), Janssen Research & Development (United States), University of Pennsylvania, Columbia University, Baylor University Medical Center, Johns Hopkins University, Mayo Clinic, Pfizer (United States)

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Pfizer

OpenAlex ID: W1978001480

FWCI: 8.613

Cites: 42

Cited by: 94

Related to: 10